Imagion Biosystems Dividend

Dividend criteria checks 0/6

Imagion Biosystems does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	1.7%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-AU$0.40
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Imagion Biosystems (ASX:IBX) Has Rewarded Shareholders With An Exceptional 582% Total Return On Their Investment

Feb 28

Here's Why We're Not Too Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Situation

Jan 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if IBX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IBX's dividend payments have been increasing.

Dividend Yield vs Market

Imagion Biosystems Dividend Yield vs Market

How does IBX dividend yield compare to the market?
Segment	Dividend Yield
Company (IBX)	n/a
Market Bottom 25% (AU)	2.6%
Market Top 25% (AU)	6.3%
Industry Average (Medical Equipment)	1.7%
Analyst forecast in 3 Years (IBX)	n/a

Notable Dividend: Unable to evaluate IBX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IBX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate IBX's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as IBX has not reported any payouts.

Imagion Biosystems Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Imagion Biosystems Limited, Annual General Meeting, May 31, 2024

Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.35 loss in FY 2022)

Imagion Biosystems Limited Announces Departure of Isaac Bright as CEO

Imagion Biosystems Limited Approves Election of Isaac Bright as Director

New major risk - Market cap size

First half 2023 earnings released: AU$0.007 loss per share (vs AU$0.005 loss in 1H 2022)

New major risk - Financial position

New minor risk - Financial data availability

Imagion Biosystems Limited Appoints Robert Proulx as Non-Executive Chairman

New minor risk - Share price stability

Imagion Biosystems Limited Announces CEO Changes

New major risk - Market cap size

Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation

Imagion Biosystems Limited Reports Positive Clinical Data At Breast Cancer Symposium

No independent directors

Here's Why We're Watching Imagion Biosystems' (ASX:IBX) Cash Burn Situation

First half 2022 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2021)

No independent directors

Imagion Biosystems Limited, Annual General Meeting, May 25, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate

We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2020)

Imagion Biosystems Limited Announces First Patient Enrolled in the MagSense® HER2 Breast Cancer Phase I First-In-Human Study

We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate

Imagion Biosystems Limited Receives CSIRO Grant for Prostate Cancer Project

Imagion Biosystems (ASX:IBX) Has Rewarded Shareholders With An Exceptional 582% Total Return On Their Investment

Full year 2020 earnings released: AU$0.007 loss per share (vs AU$0.01 loss in FY 2019)

New 90-day high: AU$0.21

New 90-day high: AU$0.21

Here's Why We're Not Too Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Situation

Imagion Biosystems Limited Provides First-In-Human Study Update - Study Open for Enrolment

Imagion Biosystems Limited Announces Change of Company Secretary

Imagion Biosystems Limited announced that it expects to receive AUD 6 million in funding

Imagion Biosystems Limited Appoints Geoff Hollis as CFO

Imagion Biosystems Announces HREC Approval for Phase I Study

First half earnings released

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies